T2 Biosystems, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
1.85
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-2.04
|
-2.95
|
-0.91
|
-44.61%
|
|
2022-06-30
|
-4.50
|
-5.00
|
-0.50
|
-11.11%
|
|
2022-03-31
|
-3.75
|
-5.00
|
-1.25
|
-33.33%
|
|
2021-12-31
|
-4.50
|
-3.50
|
1.00
|
22.22%
|
|
2021-09-30
|
-4.25
|
-4.00
|
0.25
|
5.88%
|
|
2021-06-30
|
-4.00
|
-4.00
|
0.00
|
0.00%
|
|
2021-03-31
|
-3.70
|
-3.50
|
0.20
|
5.41%
|
|
2020-12-31
|
-3.40
|
-3.50
|
-0.10
|
-2.94%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-12.95
|
|
2021-12-31
|
-15.00
|
|
2020-12-31
|
-7.81
|
|
2019-12-31
|
-1.29
|
|
2018-12-31
|
-1.28
|
|
2017-12-31
|
-1.94
|
|
2016-12-31
|
-2.11
|
|
2015-12-31
|
-2.20
|
|
2014-12-31
|
-7.51
|